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Killer cell immunoglobulin-like receptors (KIRs) are a family of cell surface inhibitory or
activating receptors expressed on natural killer cells and some subpopulations of T lym-
phocytes. KIR genes are clustered in the 19q13.4 region and are characterized by both
allelic (high numbers of variants) and haplotypic (different numbers of genes for inhibitory
and activating receptors on individual chromosomes) polymorphism. This contributes to
diverse susceptibility to diseases and other clinical situations. Associations of KIR genes,
as well as of genes for their ligands, with selected diseases such as psoriasis vulgaris and
atopic dermatitis, rheumatoid arthritis, recurrent spontaneous abortion, and non-small cell
lung cancer are discussed in the context of NK and T cell functions.
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INTRODUCTION
Killer cell immunoglobulin-like receptors (KIRs) are a family
of cell surface receptors. KIR proteins possess two (KIR2D) or
three (KIR3D) immunoglobulin-like domains in their extracellu-
lar region. KIRs are expressed on natural killer (NK) cells and some
subpopulations of T lymphocytes, and therefore may influence
the activation of both cell types. They do it either by inhibi-
tion of cell activation [inhibitory KIRs, with long (L) cytoplasmic
tail – KIR2DL and KIR3DL – which contains immunoreceptor
tyrosine-based inhibitory motifs, ITIMs], or by activation of a cell
[activating KIRs, KIR2DS, and KIR3DS, with short (S) cytoplas-
mic tail having no signaling motifs but associated with adapter
molecule, DAP12 homodimer, which possesses immunoreceptor
tyrosine-based activating motifs, ITAMs]. Upon ligand binding by
inhibitory KIR, tyrosine residues in its ITIMs become phosphory-
lated, which is recognized by a phosphatase, which then dephos-
phorylates proteins of the signaling pathway, phosphorylated pre-
viously due to cell activation. On the other hand, ligand binding
by activating KIR results in tyrosine phosphorylation in ITAMs
of DAP12 molecule, and this leads to activation of kinases of sig-
naling pathway and cell activation. KIR ligands, where known, are
HLA class I molecules (Table 1). All allomorphs of HLA-C are rec-
ognized by some inhibitory KIRs, whereas less than 50% of HLA-A
and HLA-B allomorphs present in human populations are recog-
nized by KIRs (Parham et al., 2012a). Differing in the amino acid
residue in position 80, HLA-C allomorphs fall into two groups,
C1 (Asn80) and C2 (Lys80), recognized by KIR2DL2/KIR2DL3
and KIR2DL1/KIR2DS1, respectively (Table 1). As a rule, when
inhibitory and activating KIRs have the same or similar HLA
specificity (such as KIR2DL1 and KIR2DS1), then binding of
inhibitory KIR to its ligand is characterized by higher affinity than
binding of activating KIR to the same ligand (Vales-Gomez et al.,
1998). This protects normal cells of the body, displaying normal
quantity of HLA class I molecules, against the NK cell attack (effi-
cient inhibition), but ensures killing of virus-infected or malignant
cells with low or none expression of one or all HLA class I alle-
les (non-efficient inhibition; “missing-self” theory, Ljunggren and
Kärre, 1990).
KIR genes are clustered in the leukocyte receptor complex
(LRC) of genes located in the 19q13.4 region and are characterized
by both allelic (high numbers of variants) and haplotypic (differ-
ent numbers of genes for inhibitory and activating receptors on
individual chromosomes) polymorphism (Parham et al., 2012a).
Some KIR genes (KIR3DL2, KIR3DL3, and KIR2DL4) are called
“framework genes,” because they are present in all haplotypes.
Other genes are present only in some of them, in multiple different
combinations. Haplotypes consisting mostly of inhibitory genes
(so called “A” haplotypes) tend to be associated with lower risk of
autoimmune diseases, but higher risk of viral infections than hap-
lotypes (“B” haplotypes) containing several activating KIR genes
(see Parham, 2005; Khakoo and Carrington, 2006; Kusnierczyk,
2006; Boyton and Altmann, 2007; Campbell and Purdy, 2011)1.
Associations of KIR and their HLA ligand genes have been
studied in multiple human diseases, and reviewing all of these
here would not be possible. Therefore, selected clinical conditions,
1http://www.allelefrequencies.net/diseases/dis6001a.asp
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Table 1 | Ligands of KIR molecules (based on Kusnierczyk, 2006; Graef
et al., 2009; Campbell and Purdy, 2011; Parham et al., 2012b; and
references therein, modified).
KIR Ligand
2DL1 C2
2DL2 C1 and some C2
2DL3 C1
2DL4 HLA-G1
2DL5 Unknown
2DS1 C2
2DS2 Unknown
2DS3 Unknown
2DS4 HLA-A*11, some C1 (*1601>*0102,1402),
C2 (*0502>0202>0401), and non-identified
melanoma antigen
2DS5 Unknown
3DL1 HLA-Bw4
3DL2 HLA-A*03, A*11, and microbial CpG DNA
3DL3 Unknown
3DS1 Unknown (HLA-Bw4?)
HLA-C allele groups (i.e., KIR2D ligands):
C1 (Asn80) – C*01,03,07,08,12,13,1402,1507,1601; HLA-B46.
C2 (Lys80) – C*02,04,05,06,0707,12042,1401,15(without 1507),1602,17.
most familiar to my laboratory, are summarized and discussed
below.
SKIN DISEASES: PSORIASIS AND ATOPIC DERMATITIS
PSORIASIS
Psoriasis is a multifactorial skin disease with autoimmune fea-
tures, which are manifested by T lymphocyte infiltration to both
dermis and epidermis (Lew et al., 2004) and by antipsoriatic activ-
ity of immunosuppressants such as recombinant soluble CTLA-4
(Sivamani et al., 2012). Although etiology of this disorder is still
not definitely elucidated, it is known that both environmental
and genetic factors are involved. Genome-wide association stud-
ies revealed at least 13 psoriasis susceptibility loci (PSORS1-13)2.
Among these, the strongest linkage and association was repro-
ducibly described for HLA-Cw*06 allele located on PSORS1 locus
and encoding a ligand for KIR2DL1 and KIR2DS1 receptors (see
text footnote 2). Several lines of evidence show contribution of NK
or T lymphocytes expressing NK cell receptors, among them KIRs
(Gilhar et al., 2002; Liao et al., 2006). Therefore, we examined
whether inhibitory or activating KIR genes might be associated
with susceptibility to psoriasis vulgaris, most common clinical
form of this disease. We typed 114 and 116 patients for HLA-C
alleles and KIR genes, respectively, and compared their frequencies
with those in 123 unrelated healthy control individuals. We found,
first, a strong association of psoriasis with HLA-Cw*06, which
was strongest in individuals whose age at disease onset was up to
20 years, and decreased in patient groups with later age at onset
(Luszczek et al., 2002). Not surprisingly, we found an association of
2http://omim.org/entry/177900
KIR2DS1 gene, coding for an activating receptor recognizing HLA-
Cw*06 (HLA-Cw*06 belongs to C2 group of HLA-C epitopes),
with psoriasis vulgaris. However, in contrast to HLA-Cw*06, asso-
ciation of KIR2DS1 with psoriasis seemed stronger in higher age
at onset values, although the age effect was not significant because
of small numbers of patients with late disease onset (Luszczek
et al., 2004). Very similar association of KIR2DS1 (and KIR2DL5
in addition, which was not analyzed in our study) was simultane-
ously published for Japanese population, genetically distant from
Poles (Suzuki et al., 2004), and confirmed later in Swedish and
Brazilian Caucasians with psoriasis vulgaris (Holm et al., 2005;
Jobim et al., 2008), but not in Swedes with guttate psoriasis (Holm
et al., 2005) or in Taiwanese Chinese with plaque psoriasis (Chang
et al., 2006; see Table 2). Interestingly, KIR2DS1 gene appeared
associated also with psoriatic arthritis (Martin et al., 2002b; Holm
et al., 2005; Williams et al., 2005; Table 2). In this latter disease,
both KIR2DS1 in the absence of C2, and KIR2DS2 in the absence
of C1 group HLA-C alleles were observed associated with psoriatic
arthritis (Martin et al., 2002b; Nelson et al., 2004) in addition to
other genes (HLA-B*27 and HLA-Cw*0602), although in Ameri-
can population the effect of KIR2DS1 was independent from C2
presence (Williams et al., 2005).
We observed also some effects of other KIR genes in psoriatic
patients positive for KIR2DS1: namely, increased frequency of a
deletion variant of KIR2DS4 and decreased frequency of KIR2DS3
and KIR2DS5 gene in comparison to KIR2DS1-positive controls
(Ploski et al., 2006). A seemingly protective effect of KIR2DS5 gene
presence was seen also in other diseases (Nowak et al., 2010). The
deletion variant of KIR2DS4 gene (Hsu et al., 2002a,b; Maxwell
et al., 2002, 2004) potentially encodes a soluble protein, although
this has not been proven, and its transcription level is very low
(McErlean et al., 2010).
In summary, KIR2DS1 gene seems to be a major factor in the
LRC region contributing to the susceptibility to psoriasis vulgaris
and related diseases which are also associated with a gene for its
ligand, HLA-Cw∗06.
ATOPIC DERMATITIS
Atopic dermatitis (AD) is a chronic or relapsing inflammatory
skin disorder of complex etiology, affecting up to 20% of children
and often followed later by development of asthma and other aller-
gic diseases. Multiple immunological disturbances were described.
Disruption of epidermal barrier increases a susceptibility of AD
patients to microbial infections, both bacterial (Staphylococcus
aureus in most cases) and viral (localized or disseminated infec-
tions, most often by Herpes simplex virus; De Benedetto et al.,
2009; Boguniewicz and Leung, 2011). As NK cells are among
many cell types whose activity might be biased in AD, we were
interested whether KIR and KIR ligand genotype of AD patients
would differ from that of healthy persons. We compared KIR gene
frequencies in a group of 240 patients diagnosed with AD with
those in 690 healthy individuals representative for several regions
of Poland. Distribution of KIR genes in both groups was very sim-
ilar, with one exception: KIR2DS1 gene was present less frequently
in patients than in controls. This latter observation was confirmed
on the second cohort of 201 patients from a different region of
Poland (Niepieklo-Miniewska et al., submitted).
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Table 2 | KIR2DS1 gene associations with clinical forms of psoriasis in different ethnic groups.
Diagnosis Ethnicity Number of
patients
Number of
controls
KIR2DS1
association
Odds
ratioa
P Reference
PV Polish 116 123 Yes 5.55 <0.0001 Luszczek et al. (2004)
PV Swedish 240 372 Yes 1.48 0.0234 Holm et al. (2005)
PV Braz. Cauc. 79 110 Yes 2.43 0.005 Jobim et al. (2008)
PV Japanese 96 50 Yes 2.09 <0.05 Suzuki et al. (2004)
PP Chinese 178 203 No NA NS Chang et al. (2006)
PG Swedish 80 372 No NA NS Holm et al. (2005)
PA Swedish 75 372 Yes 1.65 0.0555 Holm et al. (2005)
PA Canadian 366 299 Yes 1.60 0.004 Martin et al. (2002b)
PA Am. Cauc. 75 90 Yes 2.41 0.0046 Williams et al. (2005)
aIf not given in a publication, then calculated on the basis of its data.
Abbreviations: PV, psoriasis vulgaris; PP, plaque psoriasis; PG, guttate psoriasis; PA, psoriatic arthritis; NA, not applicable; NS, non-significant.
The reason why KIR2DS1 gene has been found associated with
psoriasis and psoriatic arthritis (see Psoriasis) but seemingly pro-
tective against another inflammatory skin disease, AD, is not clear.
Psoriasis is believed to be a Th1-regulated disease, whereas Th2
response dominates in AD (Rabin and Levinson, 2008; von Bub-
noff et al., 2010). This division is not so sharp in nature, however
(Guttman-Yasky et al., 2011), although microarray analysis con-
firms it to a great extent (Nomura et al., 2003; Choy et al., 2012).
Keratinocytes hyperproliferate in psoriasis but undergo apoptosis
in AD (Albanesi et al., 2007; Kastelan et al., 2009; Rebane et al.,
2012). Therefore, different KIR2DS1-positive cell subpopulations
may contribute to both types of the disease, resulting in opposite
associations of KIR2DS1 gene.
RHEUMATOID ARTHRITIS
Another disease, where KIR gene associations were examined, was
rheumatoid arthritis (RA). This disorder is a chronic systemic
inflammatory polyarthritis affecting about 1% of individuals in
Caucasian populations, and T cells contribute to its pathome-
chanism (Jacob and Jacob, 2012). The involvement of NK cells
in RA was also described (Dalbeth et al., 2004; Falgarone et al.,
2005). RA is a multifactorial disease, and strongest genetic asso-
ciation was reproducibly shown for so called shared epitope of
HLA-DR; however, it explains only one-third to a half of the
genetically determined susceptibility to the disease (Bowes and
Barton, 2008). The expression of KIR2DS2 molecule on T cells
with unusual phenotype, CD4+CD28-KIR+, and an association
of KIR2DS2 but not KIR2DS1 gene with vascular inflammatory
complication of RA were described by Joerg Goronzy’s group (Yen
et al., 2001). Other KIR genes were not tested by these authors.
Therefore, we compared KIR gene frequencies in 177 RA patients
and 243 control individuals. Although no differences between
the whole group of patients and controls were found (Major-
czyk et al., 2007) – similarly to simultaneously published study
of Northern Irish RA patients (Middleton et al., 2007), never-
theless KIR2DS2 gene was associated with vasculitis also in our
population of patients. In addition, frequency of KIR2DL2 gene,
not tested by Yen et al. (2001), was also increased in vasculi-
tis (Majorczyk et al., 2007). Both these genes are in very strong
linkage disequilibrium in Caucasians, which makes differentiation
between their effects impossible. However, increased frequency of
CD4+CD28− T cell clones positive for KIR2DS2 but negative for
KIR2DL2 gene expression, observed in RA vasculitis by Yen et al.
(2001), speaks for the role of the former gene in this complication
of RA. Interestingly, CD4+CD28− T cells described in RA vas-
culitis were found only in human cytomegalovirus-seropositive,
but not in HCMV-negative RA patients, and their specificity was
predominantly directed toward HCMV antigens. If they cross-
react weakly with some autoantigens, then KIR2DS2 binding to
yet unknown ligands might boost these T cells to autoaggression
(van Bergen and Koning, 2010).
Furthermore, the frequencies of KIR2DS1 and KIR3DS1 were
lower in our patients without bone erosions than in those with
erosions and controls. Another interesting finding we made was
that RA patients positive for KIR2DL3 and negative for KIR2DS3
had earlier disease diagnosis. On the other hand, we observed no
associations of KIR genes with autoantibodies: rheumatoid factor
or anti-cyclic citrullinated peptide (Majorczyk et al., 2007).
Thus, although a susceptibility to RA does not seem to be influ-
enced by particular KIR genes, some clinical manifestations of this
disease such as vasculitis, bone erosions, and age at onset, are asso-
ciated with distinct KIR genes, which might reflect participation
of different subpopulations of T and/or NK cells.
IMMUNOGENETICS OF REPRODUCTION
RECURRENT SPONTANEOUS ABORTION
Spontaneous abortion is the most frequent disorder of human
pregnancy. Approximately 10–15% of pregnancies end in miscar-
riage during the first trimester, and even many more spontaneous
abortions go undetected. Although most are sporadic and non-
recurrent, there is a subset comprising about 1% of all pregnancies
which end with recurrent spontaneous abortion (RSA). This is
defined as at least three consecutive miscarriages before 20 weeks
of gestation (Matthiesen et al., 2012). RSA may have a number of
causes (Harris, 2010; Beaman et al., 2012; Matthiesen et al., 2012),
as molecular regulation of placentation is very complex, involv-
ing both promoting and inhibitory factors secreted by several cell
types: decidual stromal cells, decidual macrophages, and decid-
ual NK (dNK) cells (Knoefler and Pollheimer, 2012). Therefore,
some of the cases may result from insufficient activity of dNK cells
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(Harris, 2010; Parham and Guethlein, 2010). NK cells constitute a
large leukocyte population in the endometrium and they come in
close contact with allogeneic extravillous trophoblast (EVT) cells
in early pregnancy decidua, which is necessary for the placenta-
tion. EVT cells, in contrast to villous trophoblast cells, do express
both maternal and paternal HLA-C molecules (Hiby et al., 2010).
Moreover, HLA-C molecules on trophoblast cells form stable het-
erotrimeric heavy chain/β2-microglobulin/peptide complexes in
contrast to decidual and other cells which express not only these
heterotrimers,but also free HLA-C heavy chains (Apps et al., 2008).
In addition, dNK cells are biased toward expression of HLA-C-
binding KIRs (Male et al., 2011). Therefore, their polymorphic
KIRs recognizing polymorphic HLA-C molecules inherited from
the father by semiallogeneic fetus may play an important role in the
outcome of pregnancy. Indeed, recent studies suggest that, in addi-
tion to their role in the innate immune response to infection and
cancer, KIR-HLA (and particularly KIR-C1/C2) interactions con-
trol a proper formation of placenta (Chazara et al., 2011; Colucci
et al., 2011; Parham et al., 2012b). Several investigators reported
some associations of KIR genes with RSA.
First, Varla-Leftherioti et al. (2003) reported a comparison of
26 Greek couples with RSA and 26 fertile couples. They observed
twice lower percentage of genotypes containing genes for all three
HLA-C binding KIR2DL receptors in RSA couples as compared
to control ones, and six times higher fraction of women not pos-
sessing KIR2DL genes present in their husbands (Varla-Leftherioti
et al., 2003). These findings were confirmed on further 15 spon-
taneously aborting women compared with 15 women undergoing
elective abortion from the Greek population; in addition, in 33.3%
of spontaneously aborting women, fetal tissue did not possess a
ligand for the inhibitory KIR(s) of the mother (Varla-Leftherioti
et al., 2005). However, both these studies were performed on
low numbers of patients and controls, and their results were
not confirmed by the same authors on larger cohorts involv-
ing different ethnic groups (Varla-Leftherioti et al., 2007, 2010).
Simultaneously, another group of investigators published a series
of thorough studies on the English population, showing that: (a)
KIR AA genotype frequency was significantly increased, and fre-
quencies of B haplotype-associated KIR genes were decreased in
95 RSA cases compared to 269 controls (Hiby et al., 2008); (b)
frequency of C2 group HLA-C alleles was significantly increased
in male partners of RSA women, whereas these women exhib-
ited an increased frequency of KIR AA genotype (which contains
C2-specific KIR2DL1 gene; Hiby et al., 2008); and (c) KIR AA fre-
quency was increased in affected mothers (i.e., combined mothers
with preeclampsia, RSA, and restricted fetal growth) only when the
fetus possessed more C2 genes than the mother, i.e., C2/C2 fetus
in C1/C2 mother and C1/C2 fetus in C1/C1 mother (Hiby et al.,
2010). This study showed also that the protective effect of haplo-
type B genes is located in telomeric part of the KIR region (TelB,
containing KIR2DS1 gene), whereas no single gene from the hap-
lotype A was found associated with RSA (Hiby et al., 2010). This
latter result is not contradicting the association of AA genotype
with RSA in England mentioned above, because all of A haplotype
genes may appear also in some B haplotypes (Parham, 2005): both
a centromeric (CenA) or telomeric (TelA) haplotype A segment
may be linked to telomeric (TelB) or centromeric (CenB) segment
from a B haplotype, respectively (Cooley et al., 2010; Parham and
Guethlein, 2010; Pyo et al., 2010; Chazara et al., 2011), and only
CenA/CenA-TelA/TelA genotypes were named “AA” in the past, all
other ones being “BB” or “Bx.”
There were also reports on KIRs and HLA-C in RSA in
other populations. Hong et al. (2008) described an association of
KIR2DL2 (a B haplotype gene), but not any other KIR gene with
RSA in Chinese (Hong et al., 2008). However, this study was made
on extremely low number of patients (N = 16) and low number of
controls (N = 41), and the result was not corrected for the number
of comparisons. Indeed, another Chinese study on higher num-
bers of individuals (73 RSA couples and 68 control couples) did
not confirm KIR2DL2 increase,but has rather shown an increase of
activating KIR genes, 2DS1 and 2DS5 and association of RSA with
higher numbers of activating KIRs (Wang et al., 2007). Similarly,
in 68 Brazilian Caucasian RSA patients, genotypes with five or six
activating KIR genes were significantly more frequent than in 68
controls (Vargas et al., 2009), although no single KIR gene reached
significance in frequency distribution in this (Vargas et al., 2009)
and other (Witt et al., 2004) study on Brazilian women. In north-
ern India, two KIR A haplotype genes, 2DL1 and 2DS4, were found
less frequently in 177 RSA patients than in 200 ethnically matched
controls; a combination of KIR2DL1 in the mother with C2/C2
genotype in both parents was also less frequent in patients, whereas
KIR2DL1 in the mother with C1/C1 genotype in both parents was
more frequent in RSA couples than in controls. There were also
some combinations of B haplotype-associated genes KIR2DS1 and
KIR2DS2 with C1 and C2 genotypes which were differently distrib-
uted among RSA couples and controls (Faridi and Agrawal, 2011).
We typed 85 Polish Caucasian women with RSA and 117 healthy
control women with at least two healthy born children for KIR
genes and HLA-C C1 and C2 markers. We also tested their part-
ners for HLA-C alleles and for C1 and C2. Similarly to some other
investigators, we did not observe any differences in frequencies of
individual KIR genes between RSA and control women (Nowak
et al., 2011b). However, we found that genotypes with low acti-
vating to inhibitory KIR ratios were overrepresented in our RSA
sample, whereas equilibrium between these two gene kinds seemed
to favor a success of pregnancy (Nowak et al., 2009). Nevertheless,
AA (most inhibitory) genotype was non-significantly less frequent
in RSA than in control (Nowak et al., 2011b), and this result was
confirmed by a significant decrease of this genotype in Turkish
RSA patients (Ozturk et al., 2012). This result does not, again,
seem to contradict the association of low activating to inhibitory
KIR ratios with RSA mentioned above, because some inhibitory
KIR genes (KIR2DL5A, KIR2DL5B) appear only in B haplotypes
and therefore contribute to lower activating to inhibitory gene
ratio, and some inhibitory KIR genes associated with A haplo-
type appear also in some B haplotypes, decreasing activating to
inhibitory KIR ratio.
Furthermore, in our study women with AA KIR and C1C2
HLA-C genotype pregnant with C2C2 males were present in con-
trol but completely absent from the RSA group, whereas C1C1
and C2C2 AA women with C2C2 partners were absent from con-
trol but present in RSA (Nowak et al., 2011b). Our results are
somewhat different from these of Hiby et al. (2010), where C1C2
AA women bearing C2C2 fetus were more frequent in affected
pregnancies (RSA included) than in control, whereas we observed
C1C2 AA women pregnant with C2C2 males only in control but
Frontiers in Immunology | NK Cell Biology January 2013 | Volume 4 | Article 8 | 4
Kus´nierczyk KIR gene associations with diseases
not in RSA (Nowak et al., 2011b). Also, C1C1 AA women with
C1C2 fetus were more frequent in affected group of Hiby et al.
(2010), but C1C1 AA mothers with C1C2 father were more fre-
quent in control than in RSA in our sample (Nowak et al., 2011b).
These results can not be directly compared, however, as we had no
possibility to HLA-C-type fetal tissue, particularly in our control,
because elective termination of normal pregnancy is legally for-
bidden in Poland except for some criminal cases and endangered
mother’s life. Therefore, in our case, we could predict fetal HLA-C
genotype and its parental origin only for some couples (e.g., C1C1
mother and C2C2 father and vice versa).
In summary, results of studies published so far frequently bring
conflicting results. The reasons for these discrepancies may be mul-
tiple. Some studied populations were genetically very distant, with
different KIR and HLA-C genotype frequencies. This is exem-
plified by opposite results with KIR2DS1 association with RSA,
negative in England (Hiby et al., 2008, 2010) but positive in China
(Wang et al., 2007). In most studies the numbers of patients and
controls were low, and extremely low in some reports, as shown in
Table 3. Some associations detected in small population samples
were not confirmed in larger cohorts. Also, criteria for inclusion
of patients and controls were not the same, as we discussed else-
where (Nowak et al., 2011b). Therefore, there seems to be a need for
standardization of studies on genetics of RSA and other pregnancy
disorders in different ethnic groups.
AN INTACT KIR2DL4 GENE DOES NOT SEEM NECESSARY FOR FEMALE
FERTILITY
KIR2DL4 differs from other KIR genes: (i) it has long cytoplasmic
tail which, however, contains only one ITIM sequence; (ii) it has a
positively charged arginine residue in the transmembrane region
which gives it a possibility to make a complex with the FcεRIγ
chain containing an ITAM sequence; (iii) it is not clonally distrib-
uted like other KIRs but expressed in all NK cells; (iv) on resting
NK cells, it is expressed mostly not at the cell surface but in early
endosomes where it can bind a soluble HLA-G molecule (its only
known ligand), which is present (in physiological conditions) only
on trophoblast cells invading decidua during early pregnancy; and
it transmits an activating rather than inhibitory signal inducing
cytokine secretion but not cytotoxicity (see a recent review by
Rajagopalan and Long, 2012, and references therein).
KIR2DL4 is one of so called framework genes, present in all
KIR haplotypes, similarly to KIR3DL2, KIR3DL3, and KIR3DP1
(Parham et al., 2012a). Therefore, interaction of KIR2DL4
expressed in dNK cells with HLA-G expressed by trophoblast was
suspected to be very important for normal pregnancy (Carosella
et al., 2001; Ober et al., 2003; Yan et al., 2007). However, healthy
born individuals with defects of HLA-G gene were detected (Ober
et al., 2003). Nevertheless, they were able to produce truncated
form of HLA-G molecules which could substitute for the normal
HLA-G (Hunt and Langat, 2009). Although KIR2DL4 gene was
believed to be present in all people worldwide, several individu-
als lacking this gene were found in different populations in recent
years. First one was an African immigrant from Bubi tribe (Bioko
island, Equatorial Guinea), a woman who delivered five healthy
children and experienced only one spontaneous abortion (Gomez-
Lozano et al., 2003). Then, several single cases from Pakistan,
Trinidad (also Pakistani by origin), South Turkey, and Solomon
Islands were reported to the allele frequency database (Gonzalez-
Galarza et al., 2011)3. We have also found, in the Polish population
of 690 healthy individuals, one woman lacking KIR2DL4 gene
(Nowak et al., 2011a). As her DNA was taken from paternity test-
ing, she must have delivered at least one baby, and therefore was
fertile. Interestingly, she had a KIR genotype identical to that of the
Bubi woman mentioned above: 3DL3-2DS2-2DL2-2DL5B-(del)-
2DS5-2DS1-3DL2. Unfortunately, her personal and family data
must have remained anonymous, as required by the Bioethical
Committee for samples from paternity testing, therefore neither
studies on her family were possible nor data on her further repro-
ductive success were available (Nowak et al., 2011a). However, her
case, and particularly that of Bubi individual, indicate that the
presence of KIR2DL4 gene is not absolutely necessary for success-
ful human reproduction, similarly to the presence of intact HLA-G
gene.
NEOPLASTIC DISEASES
Both NK cell cytotoxic activity (Herberman et al., 1975a,b;
Kiessling et al., 1975a,b) and “missing-self” phenomenon (Ljung-
gren and Kärre, 1990) were discovered in experimental mouse
models using tumor cells as targets for NK activity. Transformed
neoplastic cells are believed to escape from elimination by cyto-
toxic T cells due to a reduction or loss of some or all HLA
class I (HLA-I) molecules, which in turn exposes them to the
attack from NK cells (Ljunggren and Kärre, 1990; Bubenik, 2004;
Parham, 2005; Khakoo and Carrington, 2006; Purdy and Camp-
bell, 2009). It has been shown that NK cells may lyze not only
cells of established human tumor cell lines but also freshly isolated
human tumor cells (Carlsten et al., 2009). Since KIR phenotype
affects activity of NK cells (and subpopulations of T lympho-
cytes), one can expect that a prevalence of neoplasms may be
influenced by it. Therefore, many investigators examined distrib-
ution of KIR genes and their ligands as well as their expression in
several tumor systems, experimental and clinical (Parham, 2005;
Khakoo and Carrington, 2006; van der Meer et al., 2008). We
looked whether prevalence of non-small cell lung cancer (NSCLC)
might be associated with genes for KIRs and their ligands in the
Polish population.
NON-SMALL CELL LUNG CANCER
Non-small cell lung cancer constitutes 85% of lung cancer cases
which are a major cause of cancer mortality worldwide. It is a
multifactorial disease with a strong environmental (mostly ciga-
rette smoking) influence, but genetic factors also play a role4. In
NSCLC, NK cells infiltrate rather peritumoral than tumor tissue,
in contrast to T lymphocytes (Esendagli et al., 2008; Schneider
et al., 2011), and these NK cells which do infiltrate the tumor are
predominantly CD56bright, negative for NK cell receptors (includ-
ing KIRs), and exhibit low cytotoxic activity ex vivo (Carrega et al.,
2008; Esendagli et al., 2008). On the other hand, a tumor-specific
cytotoxic T cell clone isolated from tumor infiltrating lymphocytes
in an NSCLC patient expressed KIR3DL2 but not other KIRs,
3http://www.allelefrequencies.net/
4http://omim.org/entry/211980
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Table 3 | KIR gene associations with recurrent spontaneous abortion.
Ethnicity Number of patients Number of controls KIR association Reference
Greeks 26 Couples 26 Couples 2DL1+2DL2+2DL3 protective Varla-Leftherioti et al.
(2003)
Greeks 15 15 2DL1+2DL2+2DL3 protective; 2DL – HLA-C mismatch
associated
Varla-Leftherioti et al.
(2005)
Cauc.+Mongol. 158 81 No significant results Varla-Leftherioti et al.
(2007)
Chinese 73 Couples 68 Couples 2DL1+C2 in both partners protective; 2DS1+C2 in both
partners protective
Wang et al. (2007)
Argentina 88 Couples 139 Healthy individ. AA genotype associated; 2DL2 protective Flores et al. (2007)
Chinese 16 41 2DL2 associated Hong et al. (2008)
English Caucasian 95 Females; 67 males 269 Females Female AA associated; male C2 associated Hiby et al. (2008)
Brasilian Caucasian 68 Couples 68 Couples Five to six activating KIRs associated Vargas et al. (2009)
Poles 91 117 Six inhibitory KIRs associated; six activating KIRs protective Nowak et al. (2009)
English Caucasian 975 RSA+FGR+PE 592 Female AA associated only when fetus has more C2 than
mother
Hiby et al. (2010)
Mixed 224 182 No significant results Varla-Leftherioti et al.
(2010)
Asian Indians 177 200 Maternal 2DL1+ both partners C2C2 protective; 2DS2+
both partners C1C1 associated
Faridi and Agrawal
(2011)
Poles 85 117 Female AA C1C2+ partner C2C2 strongly protective Nowak et al. (2011b)
Turks 40 90 Female AA protective Ozturk et al. (2012)
and KIR3DL2 had neither stimulating or inhibiting effect on its
cytotoxic or interferon-gamma secreting activity (Dorothée et al.,
2003). It was also shown that a majority of T cells infiltrating a
tumor display T regulatory rather than effector cell phenotype
(Esendagli et al., 2008; Schneider et al., 2011). Thus, cells infiltrat-
ing malignant areas in NSCLC seem to be poor in KIR expression
and cytotoxic activity. Nevertheless, it is conceivable that cytotoxic
effector cells, including NK, might eliminate or reduce numbers
of potentially metastatic circulating cancer cells, as it has been
described for uveal melanoma (Maat et al., 2009).
We typed 269 NSCLC patients for KIR and KIR ligand genes
and compared the results with those of 690 unrelated healthy con-
trol individuals, all of them Polish Caucasians. No differences in
the distribution of individual KIR genes or AA and Bx genotypes
were observed (Wis´niewski et al., 2012). This finding confirms ear-
lier report of Al Omar et al. (2010) in 186 NSCLC cases and 255
controls from England and Northern Ireland. However, we found
less frequent prevalence of HLA-C C1/C2 genotype in patients
than in controls, whereas both homozygotes were more frequent
in patient group (Wis´niewski et al., 2012). This result was discor-
dant with that of Al Omar et al. (2010), who did not observe any
association of HLA-C C1 and C2 groups (encoding ligands for
KIR2DL2/3 and KIR2DL1, respectively) with NSCLC, but found
weak association of HLA-B Bw4Thr80 (coding for a ligand for
KIR3DL1) which lost significance after correction. This was not,
however, visible in our study (Wis´niewski et al., 2012). Interest-
ingly, Al Omar et al. (2010) observed a protective effect of C1/C2
genotype on the prevalence of NSCLC, but only in the presence of
KIR2DL3 gene, which we have not seen.
The reason for seemingly protective effect of C1/C2 genotype
on NSCLC prevalence needs explanation. HLA-C molecules play
two distinct roles in cellular immunity: first, they may present
antigenic peptides to CD8+ T lymphocytes, although this their
function seems less important than that of HLA-A and HLA-B;
second, they protect normal cells of the body from the attack of
NK cells equipped with HLA-C-binding inhibitory receptors such
as KIR2DL1, KIR2DL2, and KIR2DL3. HLA-C molecules partic-
ipate also in a process called “NK cell education”: these NK cells
which possess inhibitory receptors binding self HLA class I mol-
ecules, including HLA-C, are “allowed” to mature, whereas NK
cell clones devoid of such receptors remain immature and inactive
(Björkström et al., 2010; Elliott and Yokoyama, 2011; Schönberg
et al., 2011). Therefore, we can imagine that in NSCLC patients,
individuals with C1/C2 genotype may have wider repertoire of
antigenic peptides, including tumor antigens, presented to their
HLA-C-restricted CD8+ cytotoxic T cells which can eradicate
tumor cells. These individuals may also possess wider repertoire
of HLA-C-educated NK cell clones which would eliminate these
tumor cells which lost HLA-C expression. Transformed cells rela-
tively frequently loose one HLA-C allele (Carretero et al., 2008;
Mendez et al., 2009), including loss of heterozygosity in lung
cancer (So et al., 2005). In C1/C1 and C2/C2 homozygotes, this
does not change a sensitivity of cancer cells to NK-mediated lysis
because they retain the same HLA-C allomorph encoded by the
second chromosome and recognized by their mature NK cells.
In this respect, C1/C2 individuals are in a privileged position,
because even when a tumor cell retains one HLA-C allele, it is still
vulnerable to lysis by these NK cells which express KIR recognizing
a product of the second allele which had been lost (Maat et al.,
2009).
Multivariate analysis revealed an effect of KIR and HLA-
C genotype on the response of our patients to treatment
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(surgery and/or chemotherapy): KIR2DL2+, KIR2DS2+, C1/C1
individuals responded better to therapy and survived longer than
patients with other genotypes (median survival time 23 months
versus 10 months for patients with other genotypes; Wis´niewski
et al., 2012).
Why the effect of KIR2DL2 and KIR2DS2 on treatment
response and survival was seen only in the absence of C2 which
is not their ligand (or a major ligand in the case of KIR2DL2,
see Table 1)? Great majority (about 96%) of our patients (and
controls as well) possessed KIR2DL1 gene whose product strongly
interacts with C2+ HLA-C molecules (Parham, 2005; see Table 1).
Therefore, in C2+ patients, NK cells expressing KIR2DL1 would
be strongly inhibited and ineffective in C2+ tumor eradication. In
individuals of KIR2DL2+, KIR2DS2+, C1/C1 genotype this inter-
action is not possible, therefore NK cells may be activated and
kill tumor cells. KIR2DL2 interaction with C1 is much weaker
than that of KIR2DL1 with C2 (Parham, 2005), so NK cell activa-
tion would not be so strongly inhibited. On the other hand, why
C1/C1 genotype was not protective in the absence of KIR2DL2 and
KIR2DS2 in our patients, is less clear. Perhaps activating KIR2DS2
receptor, whose ligand is not known (Table 1), is necessary for
NK cell-mediated tumor cell lysis in this setting, but NK cells are
not sufficiently inhibited by a weak KIR2DL2-C1 interaction. It
is also possible that in some circumstances, e.g., when HLA-C C1
molecules are filled with a proper peptide, KIR2DS2 molecule may
bind them strongly enough to activate the cell.
Our results suggest that NSCLC patients possessing KIR2DL2
and KIR2DS2 genes but not having C2 ligand for KIR2DL1 may
respond better to treatment and survive longer than individuals
bearing other genotypes. We also indicate that C1/C2 genotype
may give some protection from the initiation of this tumor.
VIRAL INFECTIONS
Viruses infect cells and replicate inside them, forcing cell metab-
olism to produce abundant amounts of viral proteins. These are
degraded to oligopeptides, bound by HLA class I molecules and
presented to cytotoxic T cells (CD8+) like all other proteins pro-
duced within the cell (Neefjes et al., 2011). Therefore, many viruses
evolved molecular mechanisms which interfere, in different ways,
with cell surface expression of HLA class I molecules (Horst et al.,
2011). This makes a virus-producing cell resistant to cytotoxic
activity of T cells. On the other hand, the lack of one or all HLA
class I molecules makes it susceptible to lysis by NK cells. This,
however, depends on the repertoire of KIRs expressed on NK cell
clones, which, in turn, depends on KIR genotype of the given indi-
vidual (Parham, 2005; van Bergen and Koning, 2010). Associations
of several types of viral infections and resulting human diseases
with KIR genes have already been studied. Detailed review of the
results of these studies would go beyond the acceptable volume
of this article, therefore I will only mention here most important
findings.
1. HIV-1 infection results in slower progression to AIDS in indi-
viduals possessing KIR3DS1 gene and HLA-Bw4 variant encod-
ing isoleucine residue in position 80 (Martin et al., 2002a). This
discovery stimulated multiple studies which are a topic of recent
review (Koerner and Altfeld, 2012).
2. HIV-2 was much less extensively studied, because its preva-
lence is limited to West Africa, and its infection is more benign
than that of HIV-1. No strong correlation with any KIR gene
(including KIR3DS1) was observed, except for a trend for
protective effect of KIR2DL2/KIR2DS2/C1 genotype (Yindom
et al., 2010).
3. Both protective and detrimental effects of KIR2DL2 on human
T-lymphotropic myelopathy/tropical spastic paraparesis in
Japan, depending on HLA allele (Seich al Basatena et al., 2011).
4. Several KIR genes were found to be associated with H1N1
influenza 2009 pandemics (La et al., 2011; Aranda-Romo et al.,
2012).
5. Mean number of activating KIRs per genotype was lowest in
survivors of Ebola virus infection and highest in those with
fatal outcome (Wauquier et al., 2010).
6. In human papillomavirus (HPV)-induced cervical intraepithe-
lial neoplasia, protective effect of KIR3DL1 and KIR2DL1 in the
presence of their ligands, and increased risk associated with
KIR3DS1 was observed in Puerto Ricans and North Amer-
icans (Carrington et al., 2005), whereas only protection by
KIR2DL5B was found in Swedish sample (Arnheim et al., 2005).
In another HPV-induced disease, recurrent respiratory papillo-
matosis, KIR3DS1 together with KIR2DS1 appeared protective
(Bonagura et al., 2010).
7. In HCMV infection of chronic hepatitis (Hepatitis B virus-
or hepatitis C virus-induced) an expansion of NKG2C+
NK cells selectively expressing KIR2DL2 or KIR2DL3 was
described (Beziat et al., 2012). In vasculitis complication of RA,
CD4+CD28− T cells were observed only in patients infected
with HCMV, suggesting a role for HCMV in boosting T cell
autoreactivity (van Bergen and Koning, 2010).
8. Hepatitis B virus infection is common worldwide, particularly
in China where it is a cause of the highest frequency of hepato-
cellular carcinoma (HCC) in the world (Zidan et al., 2012).
A synergistic effect of a combined genotype C1C1+/Bw4-
80I+/KIR2DS4fl+/KIR2DS4del+ on HCC risk was observed
(Pan et al., 2011).
9. The role of KIR genes and molecules in HCV infection and
HCV-induced HCC was so extensively studied that covering
this topic would require a separate article. The protection from
low-dose (injection or needle stick) but not from high-dose
HCV infection was first described by Khakoo et al. (2004)
in British Caucasoids and Afroamericans. The regulation of
HCV infection by NK cells was briefly reviewed recently by
Brenndörfer and Sällberg (2012).
GENERAL REMARKS
The role of polymorphic NK cell receptors, KIRs, recognizing even
more polymorphic HLA class I molecules, in human health and
disease is gaining a constantly growing interest, and the number
of publications is growing exponentially. This review could have
touched only a fragment of this field.
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